Evidence map›Paper›PMID 40110793›Full record

ArticleJournal of chemical information and modeling2025

Lipid Shape as a Membrane Activity Modulator of a Fusogenic Antimicrobial Peptide.

Marcin Makowski, Octávio L Franco, Nuno C Santos, Manuel N Melo

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Adaptive Response ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Bridging Scales: Coarse-Grained Protein Models in Computational Biology.Advances in experimental medicine and biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marcin MakowskiGIMM - Gulbenkian Institute for Molecular Medicine, Av. Prof. Egas Moniz, Lisbon 1649-035, Portugal.
Octávio L FrancoPrograma de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, Universidade de Brasília, Campus Darcy Ribeiro, Asa Norte, Brasília, Distrito Federal 70910900, Brazil.
Nuno C SantosGIMM - Gulbenkian Institute for Molecular Medicine, Av. Prof. Egas Moniz, Lisbon 1649-035, Portugal.
Manuel N MeloInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal.ORCID 0000-0001-6567-0513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An intriguing feature of many bacterial membranes is their prevalence of non-bilayer-forming lipids, such as the cone-shaped phosphatidylethanolamines and cardiolipins. Many membrane-active antimicrobial peptides lower the bilayer-to-hexagonal phase transition energy barrier in membranes containing such types of cone-shaped lipids. Here, we systematically studied how the molecular shape of lipids affects the activity of antimicrobial peptide EcDBS1R4, which is known to be an efficient fusogenic peptide. Using coarse-grained molecular dynamics simulations, we show the ability of EcDBS1R4 to form "hourglass-shaped" pores, which is inhibited by cone-shaped lipids. The abundance of cone-shaped lipids further correlates with the propensity of this peptide to oligomerize preferentially in antiparallel dimers. We also observe that EcDBS1R4 promotes the segregation of the anionic lipids. When coupled to dimerization, this charge segregation leads to regions in the bilayer that are devoid of peptides and rich in zwitterionic lipids. Our results indicate a protective role of cone-shaped lipids in bacterial membranes against pore-mediated permeabilization by EcDBS1R4.

Indexed as

Antimicrobial Cationic PeptidesAntimicrobial PeptidesCell MembraneLipid BilayersMolecular Dynamics SimulationPhosphatidylethanolaminesAntimicrobial Cationic PeptidesAntimicrobial PeptidesLipid BilayersPhosphatidylethanolamines

Identifiers

PMID40110793
PMCPMC12818768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.